Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Replimune Group Inc shares valued at $49,157 were sold by Hill Emily Luisa on Aug 15 ’25. At $5.37 per share, Hill Emily Luisa sold 9,154 shares. The insider’s holdings dropped to 134,368 shares worth approximately $1.21 million following the completion of this transaction.
Also, Astley-Sparke Philip sold 32,279 shares, netting a total of over 260,169 in proceeds. Following the sale of shares at $8.06 each, the insider now holds 1,405,071 shares.
Before that, Xynos Konstantinos had sold 7,952 shares from its account. In a trade valued at $64,093, the Chief Medical Officer traded Replimune Group Inc shares for $8.06 each. Upon closing the transaction, the insider’s holdings decreased to 7,952 shares, worth approximately $1.32 million.
As published in a research note from BMO Capital Markets on November 03, 2025, Replimune Group Inc [REPL] has been rated up from an Underperform to a Market perform and the price target has been revised to $11. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late October. As of October 20, 2025, Wedbush has increased its “Neutral” rating to a “an Outperform” for REPL. Earlier on October 20, 2025, Piper Sandler upgraded its rating. Their new recommendation was “an Overweight” for REPL stock which previously was a “a Neutral”.
Analyzing REPL Stock Performance
On last trading session, Replimune Group Inc [NASDAQ: REPL] plunged -0.66% to $8.98. The stock’s lowest price that day was $8.62, but it reached a high of $9.175 in the same session. During the last five days, there has been a surge of approximately 5.65%. Over the course of the year, Replimune Group Inc shares have dropped approximately -28.16%. Shares of the company reached a 52-week high of $14.80 on 02/21/25 and a 52-week low of $2.68 on 07/22/25.
Support And Resistance Levels for Replimune Group Inc (REPL)
According to the 24-hour chart, there is a support level at 8.67, which, if violated, would cause prices to drop to 8.37. In the upper region, resistance lies at 9.23. The next price resistance is at 9.48. RSI (Relative Strength Index) is 60.45 on the 14-day chart, showing neutral technical sentiment.
Is Replimune Group Inc subject to short interest?
Stocks of Replimune Group Inc saw a sharp steep in short interest on 2025-10-31 dropping by -1.78 million shares to 16.1 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 17.88 million shares. A decline of -11.07% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.09 of the overall float, the days-to-cover ratio (short ratio) decline to 2.09.
Which companies own the most shares of Replimune Group Inc (REPL)?
In terms of Replimune Group Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 32.74% from the previous closing price of $9.04. Analysts anticipate Replimune Group Inc stock to reach 18 by 2025, with the lowest price target being 11. In spite of this, 5 analysts ranked Replimune Group Inc stock as Buy at the end of 2025. On October 20, 2025, Leerink Partners assigned a price target of “an Outperform” to the stock and upgraded coverage with a $13.
